CS
Candriam SCA Portfolio holdings
AUM
$17.3B
1-Year Return
21.68%
This Quarter Return
+8.93%
1 Year Return
+21.68%
3 Year Return
+102.54%
5 Year Return
+176.54%
10 Year Return
+489.52%
AUM
$14.4B
AUM Growth
-$406M
(-2.7%)
Cap. Flow
-$236M
Cap. Flow
% of AUM
-1.64%
Top 10 Holdings %
Top 10 Hldgs %
24.27%
Holding
963
New
98
Increased
340
Reduced
353
Closed
82
Top Buys
| 1 |
ZTO Express
ZTO
|
$42.9M |
| 2 |
STKL
SunOpta
STKL
|
$39.6M |
| 3 |
Kanzhun
BZ
|
$36.9M |
| 4 |
JPMorgan Chase
JPM
|
$35M |
| 5 |
Lantheus
LNTH
|
$30.3M |
Top Sells
| 1 |
Mercado Libre
MELI
|
$85.2M |
| 2 |
Microsoft
MSFT
|
$60.8M |
| 3 |
Veru
VERU
|
$53.9M |
| 4 |
Procter & Gamble
PG
|
$48.4M |
| 5 |
SGEN
Seagen Inc. Common Stock
SGEN
|
$42.9M |
Sector Composition
| 1 | Healthcare | 30.95% |
| 2 | Technology | 26.5% |
| 3 | Financials | 9.1% |
| 4 | Consumer Discretionary | 8.02% |
| 5 | Industrials | 7.34% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
301
Sempra
SRE
$51.8B
| $7.28M | 0.05% |
104,694
+11,622
| +12% | +$808K |
|
302
Amicus Therapeutics
FOLD
$2.46B
| $7.08M | 0.05% |
693,879
| – | – |
|
303
Interpublic Group of Companies
IPG
$9.89B
| $7M | 0.05% |
204,180
-237,703
| -54% | -$8.15M |
|
304
Schlumberger
SLB
$53.4B
| $6.98M | 0.05% |
154,472
+28,735
| +23% | +$1.3M |
|
305
Crown Castle
CCI
$40.9B
| $6.95M | 0.05% |
56,395
+932
| +2% | +$115K |
|
306
Blackrock
BLK
$171B
| $6.9M | 0.05% |
11,197
+620
| +6% | +$382K |
|
307
Krystal Biotech
KRYS
$4.2B
| $6.78M | 0.05% |
+92,000
| New | +$6.78M |
|
308
Pacira BioSciences
PCRX
$1.2B
| $6.76M | 0.05% |
179,901
-45,000
| -20% | -$1.69M |
|
309
Sherwin-Williams
SHW
$93.6B
| $6.74M | 0.05% |
32,555
-9,765
| -23% | -$2.02M |
|
310
Arrowhead Research
ARWR
$3.76B
| $6.73M | 0.05% |
288,054
-70,000
| -20% | -$1.64M |
|
311
Dyne Therapeutics
DYN
$1.89B
| $6.72M | 0.05% |
633,624
| – | – |
|
312
Idexx Laboratories
IDXX
$52.2B
| $6.67M | 0.05% |
14,490
-2,251
| -13% | -$1.04M |
|
313
Brookfield Renewable
BEPC
$6B
| $6.62M | 0.05% |
206,101
+197,390
| +2,266% | +$6.34M |
|
314
Telus
TU
$25.1B
| $6.6M | 0.05% |
361,735
+321,779
| +805% | +$5.87M |
|
315
Adicet Bio
ACET
$63.5M
| $6.53M | 0.05% |
1,230,763
| – | – |
|
316
Coupang
CPNG
$57.4B
| $6.5M | 0.05% |
441,600
-1,358,764
| -75% | -$20M |
|
317
Natera
NTRA
$23B
| $6.35M | 0.04% |
124,163
+69,163
| +126% | +$3.53M |
|
318
Robert Half
RHI
$3.66B
| $6.3M | 0.04% |
84,947
-56,927
| -40% | -$4.22M |
|
319
Avery Dennison
AVY
$13.1B
| $6.27M | 0.04% |
38,047
-9,111
| -19% | -$1.5M |
|
320
Hartford Financial Services
HIG
$36.7B
| $6.24M | 0.04% |
97,268
+36,746
| +61% | +$2.36M |
|
321
DexCom
DXCM
$30.6B
| $6.21M | 0.04% |
58,028
+1,462
| +3% | +$156K |
|
322
Blackstone
BX
$135B
| $6.2M | 0.04% |
76,638
+42,219
| +123% | +$3.41M |
|
323
Capital One
COF
$141B
| $6.17M | 0.04% |
69,672
+24,439
| +54% | +$2.16M |
|
|
OSH
324
DELISTED
Oak Street Health, Inc.
OSH
| $6.11M | 0.04% |
+171,495
| New | +$6.11M |
|
325
Synchrony
SYF
$28B
| $6.07M | 0.04% |
226,624
-52,991
| -19% | -$1.42M |
|